Open Access

Aging and the intramyocardial inflammatory response

Critical Care201418:638

https://doi.org/10.1186/s13054-014-0638-2

Published: 19 November 2014

Abstract

The sepsis-induced intramyocardial inflammatory response results in decreased ventricular function and myocardial damage. Chemokines such as monocyte chemoattractant protein-1 causally contribute to retention of intramyocardial mononuclear leukocytes and subsequent ventricular dysfunction during endotoxemic shock in mice and, importantly, this effect is age dependent. It is therefore useful to consider where monocyte chemoattractant protein-1 fits in the complex pathway leading to ventricular dysfunction during sepsis, why this might be an age-dependent effect, and what this implies for care of older sepsis patients.

Slimani and colleagues report that monocyte chemoattractant protein-1 (MCP-1) causally contributes to ventricular dysfunction during endotoxemic shock in mice and, importantly, this effect is age dependent [1]. It is therefore useful to consider where MCP-1 fits in the complex pathway leading to ventricular dysfunction during sepsis, why this might be an age-dependent effect, and what this implies for care of older sepsis patients.

Sepsis results in an intramyocardial inflammatory response that leads to decreased left ventricular contractility and diastolic dysfunction [2]. If the degree of ventricular dysfunction is minimal then the heart is able to increase cardiac output in response to sepsis-induced decreased systemic vascular resistance and increased venous return, which result in the familiar hyperdynamic septic circulation. Worsening septic shock is characterized by a progressive decrease in cardiac output despite aggressive volume resuscitation and decreased left ventricular afterload. In this circumstance – hypodynamic septic shock – it follows that ventricular dysfunction is a major causal contributor to adverse outcomes. Greater understanding of the intramyocardial inflammatory response is important when considering mitigating strategies.

Pathogen-associated molecular patterns, such as lipopolysaccharide (endotoxin) from Gram-negative organisms and peptidoglycan from Gram-positive organisms, bind innate immune receptors including Toll-like receptors (TLRs) [3]. TLRs are expressed on many cell types but particularly on cell lines involved in the earliest response to infecting pathogens, such as monocytes/macrophages. Subsequent intracellular signaling via nuclear factor-κB results in expression of an array of inflammatory cytokines [3].

Interestingly, cardiomyocytes express TLRs [4] (notably TLR2 and TLR4) and receptors for a variety of inflammatory cytokines so that circulating pathogen-associated molecular patterns and inflammatory cytokines [5] result in an intramyocardial inflammatory response. Cardiomyocytes respond with their own internal nuclear factor-κB signaling [4],[6], production of cytokines such as interleukin-6, chemotactic cytokines (chemokines) such as MCP-1 [7] and keratinocyte chemoattractant (KC), production of nitric oxide [8], and upregulation of cell surface adhesion molecules such as intracellular adhesion molecule-1 [9]. Adhesion molecules are also expressed on activated coronary endothelial cells and contribute to retention of circulating leukocytes in the coronary circulation [10]. Leukocytes are then drawn into the myocardium [11] down chemokine gradients. Ligation of cardiomyocyte intracellular adhesion molecule-1 by leukocytes [9],[12], fibrinogen [13], and other inflammatory molecules adversely impacts cardiomyocyte calcium handling, which results in decreased contractility [9]. This intramyocardial inflammatory response also triggers apoptotic pathways [14] that, even in the absence of significant end-stage cardiomyocyte apoptosis [15], can result in mitochondrial damage and dysfunction [16]. Thus, all aspects of the septic intramyocardial inflammatory response contribute to ventricular dysfunction. Whether chemokines such as MCP-1 and KC play a causal role or whether they are simply upregulated bystanders has not previously been fully elucidated.

A key observation by Slimani and colleagues is that increased myocardial MCP-1 expression resulted in increased numbers of intramyocardial mononuclear leukocytes and a greater decrease in ventricular contractility [1]. Fundamentally important is the further observation that this pathway causally contributes to decreased ventricular contractility because neutralization of MCP-1 abrogated these effects. The observation that similar neutralization of KC did not have the same effect provides an important negative control. These results suggest that MCP-1 attracts intramyocardial mononuclear leukocytes that then decrease contractility, as steps in a causal pathway. These investigators present left ventricular pressure and volume data so we can surmise that end-systolic elastance, as a load-independent measure of ventricular contractility, decreased with endotoxemia and was lowest in old mice.

Nuclear factor-κB signaling leading to cytokine and chemokine production increases with aging [17]. The consequences of this age-related exaggerated septic inflammatory response have not been fully explored, yet initial observations suggest that age-dependent increases in signaling via TLR4 induce greater ventricular dysfunction [18]. Slimani and colleagues have confirmed and extended these observations by considering cytokines and chemokines that have previously been found to be increased in the myocardium after a septic inflammatory stimulus (tumor necrosis factor alpha, interleukin-1β, interleukin-6, MCP-1, KC, macrophage inflammatory protein-1β), and they nicely demonstrate that increased MCP-1 does decrease contractility [1]. Neutralization of MCP-1 was approximately twice as effective in improving left ventricular ejection fraction in old mice compared with young adult mice. Age-dependent changes in inflammatory cytokine and chemokine production thus have important downstream functional effects.

These observations arise from a murine model so a number of limitations must be recognized. The peripheral blood leukocyte differential is quite different in mice, where most of the circulating leukocyte count is made up of mononuclear leukocytes. Neutrophils are under-represented compared with humans. Thus, the intramyocardial mononuclear infiltration, driven by the monocyte chemokine MCP-1, makes sense in this murine setting while lack of effect of KC, a granulocyte/neutrophil chemokine, also fits with the murine model. Nevertheless, the current results emphasize the functional importance of intramyocardial mononuclear leukocytes that are indeed observed in humans [19]. This murine model used endotoxin administration, which is not a realistic model of human sepsis but is an excellent tool to isolate and study specific pathways induced by pathogen-associated molecular patterns. We should thus be circumspect in extrapolating and interpreting the importance of this degree of ventricular dysfunction, but we can be confident in concluding that intramyocardial chemokines attracting leukocytes contribute to ventricular dysfunction and this response is exaggerated with aging.

In sum, these novel findings further support the notion that the inflammatory response and its cardiovascular consequences importantly change with age. Early intervention and resuscitation aimed at reducing the proinflammatory stimulus must continue to be emphasized in patients of all ages.

Abbreviations

KC: 

Keratinocyte chemoattractant

MCP-1: 

Monocyte chemoattractant protein-1

TLR: 

Toll-like receptor

Declarations

Authors’ Affiliations

(1)
Centre for Heart Lung Innovation, St. Paul’s Hospital, University of British Columbia

References

  1. Slimani H, Zhai Y, Yousif NG, Ao L, Zeng Q, Fullerton DA, Meng X: Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia.Crit Care 2014, 18:527.,View ArticleGoogle Scholar
  2. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984, 100: 483-490. 10.7326/0003-4819-100-4-483.View ArticleGoogle Scholar
  3. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.View ArticleGoogle Scholar
  4. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR: Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res. 2006, 72: 384-393. 10.1016/j.cardiores.2006.09.011.View ArticleGoogle Scholar
  5. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996, 183: 949-958. 10.1084/jem.183.3.949.View ArticleGoogle Scholar
  6. Boyd JH, Kan B, Roberts H, Wang Y, Walley KR: S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res. 2008, 102: 1239-1246. 10.1161/CIRCRESAHA.107.167544.View ArticleGoogle Scholar
  7. Massey KD, Strieter RM, Kunkel SL, Danforth JM, Standiford TJ: Cardiac myocytes release leukocyte-stimulating factors. Am J Physiol. 1995, 269: H980-H987.Google Scholar
  8. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992, 257: 387-389. 10.1126/science.1631560.View ArticleGoogle Scholar
  9. Davani EY, Boyd JH, Dorscheid DR, Wang Y, Meredith A, Chau E, Singhera GK, Walley KR: Cardiac ICAM-1 mediates leukocyte-dependent decreased ventricular contractility in endotoxemic mice. Cardiovasc Res. 2006, 72: 134-142. 10.1016/j.cardiores.2006.06.029.View ArticleGoogle Scholar
  10. Goddard CM, Allard MF, Hogg JC, Herbertson MJ, Walley KR: Prolonged leukocyte transit time in coronary microcirculation of endotoxemic pigs. Am J Physiol. 1995, 269: H1389-H1397.Google Scholar
  11. Granton JT, Goddard CM, Allard MF, van Eeden S, Walley KR: Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med. 1977, 155: 1977-1983. 10.1164/ajrccm.155.6.9196105.View ArticleGoogle Scholar
  12. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Harken AH, Meng X: ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. Am J Physiol Regul Integr Comp Physiol. 2002, 283: R477-R486.View ArticleGoogle Scholar
  13. Boyd JH, Chau EH, Tokunanga C, Bateman RM, Haljan G, Davani EY, Wang Y, Walley KR: Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism.Crit Care 2008, 12:R2.,View ArticleGoogle Scholar
  14. McDonald TE, Grinman MN, Carthy CM, Walley KR: Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol Heart Circ Physiol. 2000, 279: H2053-H2061.Google Scholar
  15. Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013, 187: 509-517. 10.1164/rccm.201211-1983OC.View ArticleGoogle Scholar
  16. Chagnon F, Metz CN, Bucala R, Lesur O: Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res. 2005, 96: 1095-1102. 10.1161/01.RES.0000168327.22888.4d.View ArticleGoogle Scholar
  17. Saito H, Sherwood ER, Varma TK, Evers BM: Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev. 2003, 124: 1047-1058. 10.1016/j.mad.2003.08.002.View ArticleGoogle Scholar
  18. Rosas GO, Zieman SJ, Donabedian M, Vandegaer K, Hare JM: Augmented age-associated innate immune responses contribute to negative inotropic and lusitropic effects of lipopolysaccharide and interferon gamma. J Mol Cell Cardiol. 2001, 33: 1849-1859. 10.1006/jmcc.2001.1448.View ArticleGoogle Scholar
  19. Schmittinger CA, Dunser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, Joannidis M, Moser P, Hasibeder WR, Halabi M, Steger CM: Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock. 2013, 39: 329-335. 10.1097/SHK.0b013e318289376b.View ArticleGoogle Scholar

Copyright

© Walley; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement